Resistance builds quietly. In broiler production, the cost of not acting on that fact compounds just as quietly, flock by flock, cycle by cycle.

All birds will inevitably encounter coccidiosis-inducing Eimeria protozoa. That much is certain. What is less certain, and increasingly at risk, is whether your current coccidiosis management program will still work when you need it most.

Anticoccidial resistance follows the same logic as antimicrobial resistance: the more continuously a chemical or ionophore is applied, the faster coccidia develop tolerance to it. After more than 50 years of coccidiosis management in poultry, no new pharmaceutical class has been introduced to replace the tools already in use. The options available to you today are the same ones your predecessors relied on, and they are under more pressure than ever. The resistance that builds in your flock today erodes the efficacy you’ll need tomorrow.

This is the root of the problem. Not the challenge of coccidiosis itself, which is well understood, but the narrowing window of reliable control that continuous chemical dependence creates.

The subclinical cost you’re already absorbing

Coccidiosis rarely announces itself with obvious clinical signs until performance has already deteriorated. Subclinical infection, where birds show no visible symptoms but are actively losing productive capacity, is the more common and more insidious presentation. Feed conversion worsens. Daily gain stalls. By the time the flock signals distress, the economic damage is done.

For broilers, there is no recovery window. The production cycle is too short to compensate for performance lost to subclinical gut damage. In an operating environment defined by tight margins and high feed costs, that invisible loss matters more than ever.

What nature contributes, and why it matters for resistance management

Plant-derived compounds offer a biologically credible answer to the resistance accumulation problem. Several classes of natural substances have demonstrated direct and indirect activity against coccidia:

• Saponins bind to membrane cholesterol in protozoan cells, directly impairing parasite development.
• Phenolics, flavonoids, and terpenoids support the bird’s innate immune response, reducing the cost of the immune activation that coccidial infection triggers.
• Antioxidant compounds reduce cellular oxidative stress, limiting the secondary tissue damage that accompanies a coccidial challenge.

The value of a complex natural product is not simply additive. The synergistic interaction between multiple active substances produces a response that a single-compound product cannot replicate. That complexity is what equips the bird to manage a coccidial challenge more effectively, with less dependence on chemical intervention.

The shuttle principle: buying time is the strategy

Every effective coccidiosis program is built around one concept: time. Specifically, buying enough time for birds to develop immunity while limiting the pathological cost of exposure. Vaccines and ionophores both operate on this principle; they reduce pathology to protect performance while immunity develops.

The shuttle and rotation approach extends this logic to resistance management. By rotating between treatment classes, you allow each active substance a period of reduced selection pressure, giving it time to restore efficacy for future use. The less frequently a chemical or ionophore is applied, the slower resistance builds.

A natural solution earns its place in this rotation by functioning as a genuine alternative phase, not a supplement to an existing program, but a replacement for a treatment interval. While Aflocox or Aflocox plus carries the coccidiosis management load, other treatments rest. Resistance pressure on those treatments decreases. When they return to the rotation, they work better.

The duration and positioning of the natural phase depends on the coccidial pressure your farm is managing. At low pressure, the natural solution can carry a broader portion of the program. At high pressure, it may be combined with a conventional treatment to improve overall control. The architecture of the program is farm-specific; what doesn’t change is the underlying principle.

Building a program that still works in 5 years

The investment in finding a more sustainable approach to coccidiosis management is not abstract. The anticoccidials available today are a finite resource – their efficacy is depleted by overuse and partially restored by rest. A program that builds in natural phases, using Aflocox and Aflocox Plus, actively manages that resource rather than drawing it down.

The birds benefit. The program benefits. And the tools needed next cycle, and the one after that, retain the efficacy you are counting on. The first step is an honest look at what your existing program is costing you in resistance accumulation, if not yet in visible performance loss.

Your coccidiosis program is tired. The question is whether you act on that before it stops working.